Hepatocyte growth factor releases mink epithelial cells from transforming growth factor β1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity

Molecular and Cellular Biology

Volumn 19, Issue 5, 1999, Pages 3654-3663

  Tsubari, Minna ^a   Taipale, Jussi ^a   Tiihonen, Erja ^a   Keski Oja, Jorma ^a   Laiho, Marikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLIN E; PROTEIN P15; PROTEIN P27; RETINOBLASTOMA PROTEIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; COMPLEX FORMATION; DNA REPLICATION; ENZYME ACTIVITY; ENZYME REGULATION; GROWTH INHIBITION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM;

ANIMALIA; MUSTELA VISON;

EID: 0032938746     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.5.3654     Document Type: Article

References (55)

1. Akiyama, T., T. Ohuchi, S. Sumida, K. Matsumoto, and K. Toyoshima. 1992. Phosphorylation of the retinoblastoma protein by Cdk2. Proc. Natl. Acad. Sci. USA 89:7900-7904.
2. Birchmeier, C., and W. Birchmeier. 1993. Molecular aspects of mesenchymal-epithelial interactions. Annu. Rev. Cell Biol. 9:511-540.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Bussolino, F., M. F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, L. Naldini, G. Gaudino, L. Tamagnone, A. Coffer, and P. M. Comoglio. 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:629-641.
5. Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/ Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287-301.
6. 1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J. Biol. Chem. 273:3838-3847.
7. Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang. 1995. Transforming growth factor-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. SCi. USA 92:5545-5549.
8. de Caestecker, M. P., W. T. Parks, C. J. Frank, P. Castagnino, D. P. Bottaro, A. B. Roberts, and R. J. Lechleider. 1998. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12:1587-1592.
9. Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961.
10. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009-1020.
11. Gabrielli, B. G., M. S. Lee, D. H. Walker, H. Piwnica-Worms, and J. L. Maller. 1992. Cdc25 regulates the phosphorylation and activity of the Xenopus Cdk2 protein kinase complex. J. Biol. Chem. 267:18040-18046.
12. Graña, X., and E. P. Reddy. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219.
13. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995-4005.
14. Haapajärvi, T., L. Kivinen, K. Pitkänen, and M. Laiho. 1995. Cell cycle dependent effects of U.V.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene 11:151-159.
15. Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581-1588.
16. ink4b is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261.
17. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407.
18. Iavarone, A., and J. Massagué. 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387:417-422.
19. Jeffrey, P. D., A. A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massagué, and N. P. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376:313-320.
20. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
21. Kingsley, D. M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133-146.
22. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massagué. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536-539.
23. Kretzschmar, M., J. Doody, and J. Massagué. 1997. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389:618-622.
24. Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
25. Li, C. Y., L. Suardet, and J. B. Little. 1995. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270:4971-4974.
26. Lundberg, A. S., and R. A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753-761.
27. Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380:262-265.
28. Massagué, J. 1996. TGF-β signaling: receptors, transducers, and Mad proteins. Cell 85:947-950.
29. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
30. Millar, J. B., C. H. McGowan, G. Lenaers, R. Jones, and P. Russell. 1991. p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J. 10:4301-4309.
31. Montesano, R., K. Matsumoto, T. Nakamura, and L. Orci. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908.
32. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
33. Müller, D., C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and M. Eilers. 1997. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin/Cdk2 complexes. Oncogene 15:2561-2576.
34. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
35. Ohtsubo, M., and J. M. Roberts. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912.
36. Kip1 binding to newly formed complexes. Oncogene 14: 2373-2381.
37. Pines, J. 1995. Cyclins and cyclin-dependent kinases: theme and variations. Adv. Cancer Res. 66:181-212.
38. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
39. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
40. Kip1 coordinate their inhibitory interactions with Cdk4 and Cdk2. Genes Dev. 11:492-503.
41. Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831-1845.
42. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331.
43. INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 17:2458-2467.
44. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
45. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
46. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
47. Slingerland, J. M., L. Hengst, C. H. Pan, D. Alexander, M. R. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14:3683-3694.
48. Solomon, M. J., T. Lee, and M. W. Kirschner. 1992. Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol. Biol. Cell 3:13-27.
49. Taipale, J., and J. Keski-Oja. 1996. Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-β1. J. Biol. Chem. 271:4342-4348.
50. Taipale, J., J. Saharinen, and J. Keski-Oja. 1998. Extracellular matrix associated transforming growth factor-β: role in cancer cell growth and invasion. Adv. Cancer Res. 75:87-133.
51. van den Eijnden-van Raaij, A. J., I. Koornneef, and E. J. van Zoelen. 1988. A new method for high yield purification of type β transforming growth factor from human platelets. Biochem. Biophys. Res. Commun. 157:16-23.
52. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
53. Zarkowska, T., and S. Mittnacht. 1997. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272:12738-12746.
54. KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330.
55. Cip1-related domain to bind cyclin/Cdk2 and regulate interactions with E2F. Genes Dev. 9:1740-1752.